CanSinoBIO will continue to drive the innovation and development of vaccines with a global vision by enhancing collaboration with international partners, and contributing more to ... Apr 29
Although meningitis is uncommon in India, it is still something to be concerned about. For awareness, learn more about meningitis.... Jan 07
Clinical trials are also being conducted in the US, Japan, Russia, South Africa, Kenya and Latin America with planned trials in other European and Asian ... Nov 24
AstraZeneca gears up for regulatory approvals... Nov 24
The EC has approved MenQuadfi for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.... Nov 23
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in ... Nov 23
Older adults are at a disproportionate risk of severe COVID-19 disease, so it is essential that any vaccine adopted for use against SARS-CoV-... Nov 20
A phase 1/2 trial involving 1,077 healthy adults found that the vaccine induced strong antibody and T cell immune responses up to day ... Jul 21
In a bid to strengthen its vaccine portfolio and expand into areas of unmet need, Hilleman Laboratories focuses on delivering high-impact and affordable vaccines... Jan 18
-Advertisements-
.jpeg)
Monday, November 25, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)